NCT06206746 2026-03-24
The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System
May Health
Phase NA Recruiting
Clinical Trials
48 trialsNCT05279768 2026-02-25
Stem Cells and Secretomes for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance.
PT. Prodia Stem Cell Indonesia
Phase 1/2 Completed
NCT06800170 2026-01-06
HP-phD_Adolesc
Lo.Li.Pharma s.r.l
Phase NA Recruiting
NCT05555680 2025-12-09
HIP
Clinique Ovo
Terminated
NCT04670393 2025-12-04
Antioxidant Supplement Associated With Oral Probiotics in Patients With PCOS in IVF
Fertypharm
Phase NA Completed
NCT05370521 2025-10-09
A Study of Safety and Efficacy of Tildacerfont in Females With Polycystic Ovary Syndrome and Elevated Adrenal Androgens
Spruce Biosciences
Phase 2 Terminated
NCT06963840 2025-08-29
Ova-All Care
Wellizen Australia
Phase 2 Active not recruiting
NCT03760926 2025-08-27
A Trial of the May Health Device in Transvaginal Ablation of Ovarian Tissue Under ULTRAsound Visualization in Women With PCOS Infertility
May Health
Phase NA Completed
NCT06639698 2025-07-25
PT-PHD
Lo.Li.Pharma s.r.l
Phase NA Completed
NCT03667443 2025-07-11
Myo-inositol Plus Alpha-lactalbumin in PCOS Myo-inositol-resistant Patients
Lo.Li.Pharma s.r.l
Phase NA Completed
NCT05348967 2025-06-04
Combination of D-chiro-inositol With Ketogenic Diet
Lo.Li.Pharma s.r.l
Phase NA Withdrawn
NCT06715527 2025-04-08
Treatment of Women With Hyperandrogenic PCOS With Two Different Ratios of Myo-inositol:D-chiro-inositol: A Comparison
Lo.Li.Pharma s.r.l
Phase NA Completed
NCT06912594 2025-04-06
App Impact on Quality of Life and Symptoms in PCOS
Endo Health GmbH
Phase NA Not yet recruiting
NCT05936840 2024-10-28
QMHMS
Quanovate Tech Inc.
Recruiting
NCT06124300 2024-08-23
Effects of a Female Hormone Balance Supplement on Symptoms of Polycystic Ovary Syndrome and Severe Premenstrual Syndrome
Rael
Phase NA Completed
NCT05875233 2024-07-24
A Study to Evaluate the Effect of Elix Cycle Balance and Daily Harmony on Polycystic Ovary Syndrome
Zenchi, Inc.
Phase NA Active not recruiting
NCT06507332 2024-07-18
Combination Letrozole and Clomiphene Citrate Versus Letrozole Alone
Egymedicalpedia
Phase NA Unknown
NCT04196595 2024-07-03
Apple Women's Health Study
Apple Inc.
Recruiting
NCT06367712 2024-04-16
Letrozole Alone Protocol Versus Using Letrozole and HCG Protocol
Egymedicalpedia
Phase 1 Completed
NCT05320289 2023-11-09
ULTRA-US
May Health
Phase NA Completed
NCT04981275 2023-11-01
A Multi-omic Approach to Evaluate and Characterize the Polycystic Ovary Syndrome (PCOS) Phenotype
Onegevity Health
Completed
NCT05756023 2023-10-19
IVF\ICSI Outcome in Women With Polycystic Ovary Syndrome
Egymedicalpedia
Phase NA Recruiting
NCT05678114 2023-05-16
Inositol Treatment in Different Type of PCOS Phenotype
Lo.Li.Pharma s.r.l
Phase NA Completed
NCT03951077 2022-06-08
Study of the Safety and Efficacy of Elagolix in Women With Polycystic Ovary Syndrome
AbbVie
Phase 2 Completed
NCT05340634 2022-04-28
Evaluation of Metionac for the Modulation of Metabolic and Endocrine Parameters in Patients With PCOS.
Margan Biotech
Phase 4 Completed
NCT02865915 2021-02-01
MLE4901 vs. Placebo for the Treatment of PCOS
Millendo Therapeutics, Inc.
Phase 2 Terminated
NCT03152591 2021-01-05
PCOS
Novartis
Phase 2 Completed
NCT04029805 2020-07-10
Evaluation of a Combination of a Plant Extract and a Probiotic on Glucidic Metabolism in Women With PCOS and High Insulin Levels
Biosearch S.A.
Phase 1/2 Unknown
NCT03673995 2020-06-16
Myoinositol Plus L-tyrosine, Selenium and Chromium in PCOS
Pharmarte srl
Phase NA Completed
NCT01999686 2019-05-28
POSITIF
Dexa Medica Group
Phase 3 Completed
NCT03201601 2019-01-10
Evaluation of the Mixture Myoinositol:D-chiro-inositol 3.6:1 in Women With Polycystic Ovary Syndrome
Biosearch S.A.
Phase 2/3 Completed
NCT01733459 2018-07-26
Efficacy and Safety of DLBS3233 in Subjects With Polycystic Ovary Syndrome (PCOS)
Dexa Medica Group
Phase 3 Completed
NCT02607293 2018-06-28
ARTIST
Merck KGaA, Darmstadt, Germany
Completed
NCT03119077 2018-05-17
Single Ascending Dose, First-in-Human Study on Safety, Tolerability and Pharmacokinetics of BAY1161116
Bayer
Phase 1 Terminated
NCT03422289 2018-02-06
Improved Effects of MI Plus Alpha-LA in PCOS
Lo.Li.Pharma s.r.l
Phase NA Completed
NCT02801565 2016-11-28
Clinical Observation of Recombinant Human Growth Hormone Injection Assisted IVF-ET in the Treatment of PCOS
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase NA Unknown
NCT02328404 2016-08-04
The Effect of Vitamin D Supplementation Among Overweight Jordanian Women With Polycystic Ovary Syndrome (PCOS)
Hayat Pharmaceutical Co. PLC
Phase 3 Completed
NCT01653743 2016-01-07
Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women
Merck KGaA, Darmstadt, Germany
Phase 3 Completed
NCT01872078 2015-10-12
A Study of AZD4901 in Females With Polycystic Ovary Syndrome
AstraZeneca
Phase 2 Completed
NCT01638988 2015-07-28
Clomifene Citrate Versus Metformin in First-line Treatment of Infertility in Patients With Polycystic Ovary Syndrome and a Resistance to Insulin
Clinique Ovo
Phase 3 Withdrawn
NCT01969396 2014-12-23
Evaluation of the Goldstein SonoBiopsy™ Catheter for Diagnosing Endometrial Pathology
Cook Group Incorporated
Phase NA Terminated
NCT01081639 2014-07-31
To Evaluate the Convenience, Safety and Efficacy of Follitropin Alfa Liquid Pen Compared With Follitropin Beta Liquid Pen
Merck KGaA, Darmstadt, Germany
Phase 3 Completed
NCT01081626 2014-02-13
Recombinant Follicle Stimulating Hormone (FSH) (Gonal-f®): Use in Ovulation Induction
Merck KGaA, Darmstadt, Germany
Phase 4 Completed
NCT01185704 2014-02-13
ATTAC-PCO
Merck KGaA, Darmstadt, Germany
Phase 3 Completed
NCT01185782 2013-12-27
SJ-0021 (Gonalef®) Versus Purified Pituitary Gonadotropin (Fertinorm-P®) for Ovulation Induction in Japanese Infertile Women
Merck KGaA, Darmstadt, Germany
Phase 3 Completed
NCT01051024 2012-05-04
Diamel in the Treatment of Polycystic Ovary Syndrome
Catalysis SL
Phase 3 Completed
NCT00805935 2012-01-27
Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS)
Ferring Pharmaceuticals
Phase 4 Completed
NCT01366391 2011-06-06
Therapeutic Monitoring of Metformin in Women With Polycystic Ovary Syndrome
Biocinese
Phase 4 Unknown